Tag:

Edge Therapeutics

Latest Headlines

Edge picks MPI to test 3 brain injury treatments

April 5, 2012

MPI Research and Edge Therapeutics have partnered to conduct trials toward the testing of products they hope can combat the effects of brain hemorrhage.

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Director, Clinical Safety
Daiichi Sankyo - Edison, NJ
Neurosciences Knowledge Group Lead
Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US
Senior Manager, Clinical Data Management
TESARO - Waltham, MA
Pilot Manufacturing Scientist Job
Yoh - Cambridge, MA, USA

Edge Therapeutics

Latest Headlines

Latest Headlines

Edge picks MPI to test 3 brain injury treatments

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Edge Therapeutics

Latest Headlines

Latest Headlines

Edge picks MPI to test 3 brain injury treatments

Related Tags